Search
for
Sort by
Research 391–420 of 1000+
- Ritlecitinib: First Approval
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection
- A Nonredundant Human Protein Chip for Antibody Screening and Serum Profiling
- Tofacitinib for the treatment of lichen planopilaris: A case series
- Mice with Alopecia, Osteoporosis, and Systemic Amyloidosis Due to Mutation in Zdhhc13, a Gene Coding for Palmitoyl Acyltransferase
- Protein Microarrays
- Molecular characterization of xerosis cutis: A systematic review
- A novel therapeutic paradigm for patients with extensive alopecia areata
- PBX homeobox 1 enhances hair follicle mesenchymal stem cell proliferation and reprogramming through activation of the AKT/glycogen synthase kinase signaling pathway and suppression of apoptosis
- Recent Formulation Advances of Mangiferin
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Baicalin increases hair follicle development by increasing canonical Wnt/β‑catenin signaling and activating dermal papillar cells in mice
- Targeted inactivation of integrin-linked kinase in hair follicle stem cells reveals an important modulatory role in skin repair after injury
- Innovations in Skin and Soft Tissue Aging—A Systematic Literature Review and Market Analysis of Therapeutics and Associated Outcomes
- Establishment of keratinocyte cell lines from human hair follicles
- Essential Role for Integrin-Linked Kinase in Melanoblast Colonization of the Skin
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- A review of Janus kinase inhibitor use in scarring alopecia
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Effects of a complex mixture prepared from agrimonia, houttuynia, licorice, peony, and phellodendron on human skin cells
- Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events
- Resistance Training Ameliorates Finasteride-Induced Disturbance in Protein Homeostasis in Skeletal Muscle of Rats
- Hair Follicle Reconstruction and Stem Cells
- Performance exploration of multi-gene panels of alopecia areata susceptibility and drug-binding targets
- Combination of Transcriptomics and Proteomics Reveals Differentially Expressed Genes and Proteins in the Skin of EDAR Gene-Targeted and Wildtype Cashmere Goats
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review